Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Onconova Therapeutics Inc (NASDAQ:ONTX)

1.60
Delayed Data
As of 4:00pm ET
 +0.04 / +2.56%
Today’s Change
1.53
Today|||52-Week Range
4.12
-29.52%
Year-to-Date
No recent news for Onconova Therapeutics Inc.

Today’s Trading

Previous close1.56
Today’s open1.53
Day’s range1.53 - 1.60
Volume16,298
Average volume (3 months)90,990
Market cap$15.4M
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+57.71%
Earnings growth (this year)+24.85%
Earnings growth (next 5 years)--
Revenue growth (last year)-51.59%
P/E ratioNM
Price/Sales1.81
Price/Book2.45

Competitors

 Today’s
change
Today’s
% change
IMRNImmuron Ltd-0.45-7.89%
ABIOARCA Biopharma Inc+0.02+2.00%
NVGNNovogen Ltd0.000.00%
EYEGEyeGate Pharmaceutic...+0.09+9.68%
Data as of 4:00pm ET, 08/18/2017

Financials

Last reporting dateAugust 15, 2017
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$5.5M
Annual profit (last year)-$19.7M
Net profit margin-354.62%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ramesh Kumar
CFO &
Principal Accounting Officer
Mark Guerin
Corporate headquarters
Newtown, Pennsylvania

Forecasts